177 related articles for article (PubMed ID: 26503892)
1. Temporal Phosphoproteome Dynamics Induced by an ATP Synthase Inhibitor Citreoviridin.
Hu CW; Hsu CL; Wang YC; Ishihama Y; Ku WC; Huang HC; Juan HF
Mol Cell Proteomics; 2015 Dec; 14(12):3284-98. PubMed ID: 26503892
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic analysis of human lung tumor xenografts treated with the ectopic ATP synthase inhibitor citreoviridin.
Wu YH; Hu CW; Chien CW; Chen YJ; Huang HC; Juan HF
PLoS One; 2013; 8(8):e70642. PubMed ID: 23990911
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells.
Chang HY; Huang TC; Chen NN; Huang HC; Juan HF
Cell Death Dis; 2014 Nov; 5(11):e1540. PubMed ID: 25429617
[TBL] [Abstract][Full Text] [Related]
4. Ectopic ATP synthase blockade suppresses lung adenocarcinoma growth by activating the unfolded protein response.
Chang HY; Huang HC; Huang TC; Yang PC; Wang YC; Juan HF
Cancer Res; 2012 Sep; 72(18):4696-706. PubMed ID: 22822083
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of a Novel Deguelin Derivative, L80, which Disrupts ATP Binding to the C-terminal Domain of Heat Shock Protein 90.
Lee SC; Min HY; Choi H; Kim HS; Kim KC; Park SJ; Seong MA; Seo JH; Park HJ; Suh YG; Kim KW; Hong HS; Kim H; Lee MY; Lee J; Lee HY
Mol Pharmacol; 2015 Aug; 88(2):245-55. PubMed ID: 25976766
[TBL] [Abstract][Full Text] [Related]
6. 3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways.
Wang H; Sun M; Guo J; Ma L; Jiang H; Gu L; Wen H; Liao S; Chen J; Zeng B; Li Y; Li Y; Yu X; Feng Y; Zhou Y
Biochem Pharmacol; 2017 Jul; 135():35-49. PubMed ID: 28288818
[TBL] [Abstract][Full Text] [Related]
7. Effect of citreoviridin and isocitreoviridin on beef heart mitochondrial ATPase.
Sayood SF; Suh H; Wilcox CS; Schuster SM
Arch Biochem Biophys; 1989 May; 270(2):714-21. PubMed ID: 2523213
[TBL] [Abstract][Full Text] [Related]
8. Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers.
Kotani H; Adachi Y; Kitai H; Tomida S; Bando H; Faber AC; Yoshino T; Voon DC; Yano S; Ebi H
Oncogene; 2018 Mar; 37(13):1775-1787. PubMed ID: 29348459
[TBL] [Abstract][Full Text] [Related]
9. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
10. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.
Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS
Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic Acid-mediated Inhibition of Heat Shock Protein 90-p23 Chaperone Complex and Downstream Client Proteins in Lung and Breast Cancer.
Mouradian M; Ma IV; Vicente ED; Kikawa KD; Pardini RS
Nutr Cancer; 2017 Jan; 69(1):92-104. PubMed ID: 27880046
[TBL] [Abstract][Full Text] [Related]
12. Identification of 4-anilino-3-quinolinecarbonitrile inhibitors of mitogen-activated protein/extracellular signal-regulated kinase 1 kinase.
Mallon R; Feldberg L; Kim S; Collins K; Wojciechowicz D; Kohler C; Kovacs D; Discafani C; Zhang N; Wu B; Floyd B; Powell D; Berger D
Mol Cancer Ther; 2004 Jun; 3(6):755-62. PubMed ID: 15210862
[TBL] [Abstract][Full Text] [Related]
13. Influence of efrapeptin, aurovertin and citreoviridin on the mitochondrial adenosine triphosphatase from Trypanosoma cruzi.
Cataldi de Flombaum MA; Stoppani AO
Mol Biochem Parasitol; 1981 Jul; 3(3):143-55. PubMed ID: 6454845
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibitory activity of citreoviridin against HIV-1 and an HIV-associated opportunist: Candida albicans.
Vieta I; Savarino A; Papa G; Vidotto V; Cantamessa C; Pugliese A
J Chemother; 1996 Oct; 8(5):351-7. PubMed ID: 8957714
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
Kim EJ; Juhnn YS
J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of mitogen-activated protein kinase is inhibited by calcitonin in DU145 prostate cancer cells.
Segawa N; Nakamura M; Nakamura Y; Mori I; Katsuoka Y; Kakudo K
Cancer Res; 2001 Aug; 61(16):6060-3. PubMed ID: 11507054
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
[TBL] [Abstract][Full Text] [Related]
18. Citreoviridin, a specific inhibitor of the mitochondiral adenosine triphosphatase.
Linnett PE; Mitchell AD; Osselton MD; Mulheirn LJ; Beechey RB
Biochem J; 1978 Mar; 170(3):503-10. PubMed ID: 148274
[TBL] [Abstract][Full Text] [Related]
19. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
Tang Q; Wu J; Zheng F; Hann SS; Chen Y
Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
[TBL] [Abstract][Full Text] [Related]
20. Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non-small cell lung cancer.
Bao R; Lai CJ; Wang DG; Qu H; Yin L; Zifcak B; Tao X; Wang J; Atoyan R; Samson M; Forrester J; Xu GX; DellaRocca S; Borek M; Zhai HX; Cai X; Qian C
Mol Cancer Ther; 2009 Dec; 8(12):3296-306. PubMed ID: 19952121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]